Mechanosensitive GPCRs

 Typically, hormones and/or medications tell our blood vessels what to do. But what if the blood vessels themselves could sense the pressure and then change their conformation? We all love a good old classic GPCR receptor. The GPCR receptor sits in the membrane and changes shape when a ligand binds to it. This activates an internal G-protein, which then triggers the downstream enzymes or channels to amplify the signal in the cell. A new study has shown that these GPCRs can also respond to pressure, making them act like mechanosensors. In addition to ligands, pressure, force, and stretch may act on these receptors. This is important in the understanding of things like blood pressure, vascular regulation, and cardiovascular disease.

    When a GPCR is exposed to these mechanical forces, like the stretching of a blood vessel due to high blood pressure, it will physically distort the receptor even without a ligand bound to it. Leading it to respond by only using the mechanical stress. The receptor that has been acted on by mechanical force will send slightly different G-protein cascades that regulate vascular tone, cytoskeleton remodeling, and endothelial nitric oxide release. Some mechanosensitive GPCRs, like the Angiotensin II type 1 receptor, can even switch between ligand-dependent and pressure-dependent signaling. This dual activation is what makes these receptors so important in vascular physiology, as they respond instantly to hemodynamic forces, which can offer rapid blood vessel tone adjustment without having to wait for hormonal signals.

    There is still a lot of research to be done on this topic, which leaves some things that we dont fully understand quite yet. Not all GPCRs are mechanosensitive, and it might depend on certain conditions that are unclear as of now. Most of the evidence comes from in vitro or cellular studies and has not been seen or studies in vivo as of yet. 

    The mechanosensitive GPCRs act as a new layer of control for blood pressure regulation, allowing vessels to immediately dilate to change the pressure in the vessels. The AT1R receptor is found in the arteries. When arterial pressure increases, it will activate this receptor and help to regulate the pressure. When this system becomes dysregulated in hypertension, heart failure, or vascular remodeling, it may lead to inflammation and maladaptive vasoconstriction. Using these receptors as a therapeutic target can reduce harmful pressure-sensing activity without disrupting normal hormone signaling. This could offer a promising direction for future cardiovascular therapies.

references: 

Lin, H. H., Ng, K. F., Chen, T. C., & Tseng, W. Y. (2022). Ligands and Beyond: Mechanosensitive Adhesion GPCRs. Pharmaceuticals (Basel, Switzerland), 15(2). https://doi.org/10.3390/PH15020219

Mederos Y Schnitzler, M., Storch, U., & Gudermann, T. (2011). AT1 receptors as mechanosensors. Current Opinion in Pharmacology, 11(2), 112–116. https://doi.org/10.1016/J.COPH.2010.11.003

Shetty, A. J., Sirbu, A., & Annibale, P. (2025). Insights into new mechanosensitive behaviors of G protein-coupled receptors. Journal of Molecular Endocrinology, 75(2), e240147. https://doi.org/10.1530/JME-24-0147

Sun, S., & Wang, W. (n.d.). Mechanosensitive adhesion G protein-coupled receptors: Insights from health and disease. https://doi.org/10.1016/j.gendis.2024.101267

Xiao, R., Liu, J., & Shawn Xu, X. Z. (2023). Mechanosensitive GPCRs and ion channels in shear stress sensing. Current Opinion in Cell Biology, 84. https://doi.org/10.1016/J.CEB.2023.102216